Secondary Causes of Hypertension

Common Secondary Causes

• The American College of Cardiology recommends screening for secondary hypertension when patients present with resistant hypertension, early-onset hypertension, abrupt onset or worsening of blood pressure control, or specific clinical clues suggesting an underlying cause 1, 2
• Renal Parenchymal Disease has a prevalence of 1-2% and can be identified by looking for history of urinary tract infections, obstruction, hematuria, urinary frequency, nocturia, analgesic abuse, or family history of polycystic kidney disease 1
• Renovascular Disease has a prevalence of 5-34% depending on clinical context and can be suspected in patients with resistant hypertension, abrupt onset or worsening hypertension, flash pulmonary edema, or early-onset hypertension especially in women 1, 2
• Primary Aldosteronism has a prevalence of 8-20% in resistant hypertension and can be suspected in patients with resistant hypertension, spontaneous or diuretic-induced hypokalemia, muscle cramps or weakness, incidentally discovered adrenal mass, obstructive sleep apnea, or family history of early-onset hypertension or stroke 1, 2, 3
• Obstructive Sleep Apnea has a prevalence of 25-50% in resistant hypertension and can be identified by looking for snoring, fitful sleep, breathing pauses during sleep, daytime sleepiness, obesity, Mallampati class III-IV, and loss of normal nocturnal BP fall 1, 2
• The American College of Cardiology recommends screening for drug-induced hypertension by reviewing all medications including NSAIDs, oral contraceptives, decongestants, stimulants, and herbal supplements before pursuing expensive workup 1, 2

Uncommon Secondary Causes

• Pheochromocytoma/Paraganglioma can present with episodic symptoms, labile hypertension, and pallor, and can be screened with 24-hour urinary catecholamines or metanephrines 1, 2
• Cushing Syndrome can be identified by looking for weight gain, moon facies, buffalo hump, purple striae, proximal muscle weakness, and can be screened with 24-hour urinary free cortisol or overnight dexamethasone suppression test 1
• Thyroid Disorders can cause isolated systolic hypertension or diastolic hypertension and can be screened with thyroid-stimulating hormone 1, 2
• Aortic Coarctation can be suspected in young patients with hypertension, and can be confirmed with echocardiogram or thoracic/abdominal CT angiogram or MRA 3, 4
• Primary Hyperparathyroidism can present with hypercalcemia and can be screened with serum calcium and confirmed with serum parathyroid hormone 3

Clinical Indications for Screening

• The American College of Cardiology recommends screening for secondary hypertension when any of the following are present: resistant hypertension, severe or accelerated/malignant hypertension, abrupt onset or sudden deterioration of previously controlled hypertension, hypertensive urgency or emergency, target organ damage disproportionate to duration or severity of hypertension, or unprovoked hypokalemia 1, 2, 4

Diagnostic Approach

• The American College of Cardiology recommends a thorough history, physical examination, and basic blood biochemistry as initial screening for all suspected cases of secondary hypertension 2
• Targeted screening based on clinical suspicion may include plasma aldosterone-to-renin ratio for primary aldosteronism, renal ultrasound with Doppler for renovascular disease, polysomnography for obstructive sleep apnea, and 24-hour urinary catecholamines or metanephrines for pheochromocytoma 2

Management Principles

• The American Heart Association recommends treating the underlying cause of secondary hypertension whenever possible, as this can lead to cure or dramatic improvement and reduce cardiovascular risk 3, 2
• Treatment options may include unilateral laparoscopic adrenalectomy for unilateral primary aldosteronism, medical therapy for atherosclerotic renovascular disease, percutaneous transluminal renal angioplasty without stenting for fibromuscular dysplasia, CPAP therapy for moderate-severe obstructive sleep apnea, and optimization of antihypertensive therapy while addressing the underlying cause 2, 3

Secondary Hypertension Diagnosis and Management

Patient Evaluation and Screening

• The American College of Cardiology recommends screening for secondary causes of hypertension in patients with resistant hypertension, severe hypertension, or abrupt onset of hypertension, and the European Society of Cardiology suggests plasma aldosterone-to-renin ratio for all adults with confirmed hypertension 5
• The presence of hypokalemia, although often absent, is a clue to primary aldosteronism, and normal potassium levels do not exclude the diagnosis, according to the American Heart Association 6
• A thorough medication review, including over-the-counter drugs and supplements, is essential to identify potential causes of drug-induced hypertension, as recommended by the Trends in Cardiovascular Medicine 5
• Heavy alcohol intake, defined as ≥30 drinks per week, significantly increases the risk of treatment-resistant hypertension, as reported in the journal Hypertension 6

Treatment and Management

• CPAP therapy modestly lowers blood pressure and cardiovascular risk in patients with obstructive sleep apnea, as stated in the Trends in Cardiovascular Medicine 5
• Unilateral adrenalectomy is curative for unilateral primary aldosteronism, while bilateral disease requires mineralocorticoid receptor antagonists like spironolactone 50-100 mg daily, according to the Trends in Cardiovascular Medicine 5
• Fibromuscular dysplasia, typically found in women in their early 50s, responds to angioplasty without stenting, and atherosclerotic renal artery stenosis should be managed medically in most patients, as recommended by the Trends in Cardiovascular Medicine 5

Epidemiology and First‑Line Evaluation of Common Causes of Secondary Hypertension

Prevalence of Major Secondary Hypertension Etiologies

• Renal parenchymal disease is the leading cause of secondary hypertension, out‑ranking renovascular disease, primary aldosteronism, and obstructive sleep apnea. 7, 8
• Renovascular disease affects roughly 2 % of all individuals with hypertension, but its prevalence escalates to 5–34 % among patients with resistant hypertension. 7, 8

Diagnostic Priorities

• Renal ultrasound is the recommended first‑line imaging test for suspected renal parenchymal disease, providing information on kidney size, cortical thickness, urinary‑tract obstruction, and renal masses. 7

Clinical Red‑Flag Trigger for Secondary Hypertension Work‑up

• The appearance of an abrupt onset or sudden deterioration of previously controlled blood pressure should trigger evaluation for secondary causes of hypertension. 7

Secondary Hypertension: Prevalence, Etiologies, and Evidence‑Based Screening

Epidemiology

• Primary (essential) hypertension accounts for approximately 90‑95 % of all hypertension cases, whereas secondary hypertension comprises 5‑10 % of cases in the general population and rises to 10‑35 % among patients with resistant hypertension【9】.

Common Secondary Causes

Renal Parenchymal Disease

• Prevalence 1‑2 % in adults with hypertension. Typical clues include a history of urinary infections, hematuria, nocturia, analgesic overuse, or a family history of polycystic kidney disease; physical examination may reveal a palpable abdominal mass; the preferred initial screening test is renal ultrasound【9】.

Renovascular Disease

• Found in 5‑34 % of patients with resistant hypertension. Clinical signals are resistant or abruptly worsening hypertension, flash pulmonary edema (atherosclerotic form), early‑onset hypertension in women (fibromuscular dysplasia), or a ≥50 % rise in serum creatinine after initiating an ACE‑inhibitor/ARB. Examination may show abdominal or peripheral bruits. Renal duplex Doppler ultrasound is the first‑line screening, with CT/MR renal angiography or selective intra‑arterial angiography used for confirmation【9】.

Primary Aldosteronism

• Present in 8‑20 % of resistant hypertension cases. Clues include resistant hypertension, spontaneous or diuretic‑induced hypokalemia, muscle cramps, adrenal incidentaloma, obstructive sleep apnea, or a family history of early‑onset hypertension/stroke < 40 y. Arrhythmias (especially atrial fibrillation) may be noted on exam. The 2024 European Society of Cardiology (ESC) guidelines recommend measuring the plasma aldosterone‑to‑renin ratio (ARR) in all adults with confirmed hypertension (Class IIa); confirmatory testing involves oral sodium loading, IV saline infusion, adrenal imaging, or adrenal vein sampling【9】.

Obstructive Sleep Apnea (OSA)

• Detected in 25‑50 % of resistant hypertension patients. Typical features are snoring, witnessed apneas, daytime sleepiness, and a non‑dipping nocturnal BP pattern. Physical findings include obesity, high Mallampati score, and neck circumference > 40 cm. Screening can be performed with the Berlin Questionnaire or home sleep‑apnea testing; definitive diagnosis requires polysomnography【9】.

Drug‑Induced Hypertension

• Common offending agents are NSAIDs, oral contraceptives, decongestants, stimulants, corticosteroids, cyclosporine, erythropoietin, and certain herbal supplements (e.g., licorice, ephedra). The American College of Cardiology (ACC) advises a comprehensive medication review before pursuing costly diagnostic work‑up【9】.

Pheochromocytoma / Paraganglioma

• Presents with episodic sweating, palpitations, headaches, and labile or paroxysmal hypertension. Screening utilizes 24‑hour urinary or plasma metanephrines; imaging (CT/MRI) confirms the tumor【9】.

Cushing Syndrome

• Characterized by central obesity, wide purple striae, easy bruising, proximal muscle weakness, moon face, and buffalo hump. Screening includes 24‑hour urinary free cortisol, overnight dexamethasone suppression, or late‑night salivary cortisol【9】.

Thyroid Disorders

• Hyperthyroidism (heat intolerance, tremor, weight loss, tachycardia) and hypothyroidism (cold intolerance, weight gain, delayed reflexes) can elevate BP. TSH measurement is the screening test【9】.

Aortic Coarctation

• Typically identified in younger patients with a systolic BP difference > 10 mmHg between arm and leg, radio‑femoral delay, and diminished femoral pulses. Confirmation is via echocardiography or CT/MR angiography【9】.

Primary Hyperparathyroidism

• Hypercalcemia is the hallmark; screening with serum calcium followed by parathyroid hormone measurement confirms the diagnosis【9】.

Red‑Flag Indicators Prompting a Secondary Hypertension Work‑Up (ACC)

• Hypertension onset < 30 y (especially pre‑pubertal) or > 50 y.
• Resistant hypertension: BP > 140/90 mmHg despite optimal doses of ≥ 3 antihypertensives, including a diuretic.
• Severe hypertension: SBP > 180 mmHg or DBP > 110 mmHg, or hypertensive emergency.
• Abrupt onset or sudden worsening of previously controlled BP.
• Disproportionate target‑organ damage relative to BP duration/severity.
• Absence of family history of hypertension in a young patient.
• Unprovoked hypokalemia【9】.

Clinical Pitfalls

• Normal potassium does not exclude primary aldosteronism; hypokalemia is absent in the majority of cases【9】.

All statements are supported by citation 9 (Circulation, 2018).